An enzyme that catalyzes the eliminative degradation of polysaccharides containing 1,4-beta-D-hexosaminyl and 1,3-beta-D-glucuronosyl or 1,3-alpha-L-iduronosyl linkages to disaccharides containing 4-deoxy-beta-D-gluc-4-enuronosyl groups. (Enzyme Nomenclature, 1992)
Enzymes which catalyze the elimination of delta-4,5-D-glucuronate residues from polysaccharides containing 1,4-beta-hexosaminyl and 1,3-beta-D-glucuronosyl or 1,3-alpha-L-iduronosyl linkages thereby bringing about depolymerization. EC 4.2.2.4 acts on chondroitin sulfate A and C as well as on dermatan sulfate and slowly on hyaluronate. EC 4.2.2.5 acts on chondroitin sulfate A and C.
Derivatives of chondroitin which have a sulfate moiety esterified to the galactosamine moiety of chondroitin. Chondroitin sulfate A, or chondroitin 4-sulfate, and chondroitin sulfate C, or chondroitin 6-sulfate, have the sulfate esterified in the 4- and 6-positions, respectively. Chondroitin sulfate B (beta heparin; DERMATAN SULFATE) is a misnomer and this compound is not a true chondroitin sulfate.
A naturally occurring glycosaminoglycan found mostly in the skin and in connective tissue. It differs from CHONDROITIN SULFATE A (see CHONDROITIN SULFATES) by containing IDURONIC ACID in place of glucuronic acid, its epimer, at carbon atom 5. (from Merck, 12th ed)
A mucopolysaccharide constituent of chondrin. (Grant & Hackh's Chemical Dictionary, 5th ed)
Proteoglycans consisting of proteins linked to one or more CHONDROITIN SULFATE-containing oligosaccharide chains.
Heteropolysaccharides which contain an N-acetylated hexosamine in a characteristic repeating disaccharide unit. The repeating structure of each disaccharide involves alternate 1,4- and 1,3-linkages consisting of either N-acetylglucosamine or N-acetylgalactosamine.
Glycoproteins which have a very high polysaccharide content.
A small leucine-rich proteoglycan that interacts with FIBRILLAR COLLAGENS and modifies the EXTRACELLULAR MATRIX structure of CONNECTIVE TISSUE. Decorin has also been shown to play additional roles in the regulation of cellular responses to GROWTH FACTORS. The protein contains a single glycosaminoglycan chain and is similar in structure to BIGLYCAN.
Inorganic salts of sulfuric acid.
Unstable isotopes of sulfur that decay or disintegrate spontaneously emitting radiation. S 29-31, 35, 37, and 38 are radioactive sulfur isotopes.
Enzymes which catalyze the elimination of glucuronate residues from chondroitin A,B, and C or which catalyze the hydrolysis of sulfate groups of the 2-acetamido-2-deoxy-D-galactose 6-sulfate units of chondroitin sulfate. EC 4.2.2.-.
Macromolecular organic compounds that contain carbon, hydrogen, oxygen, nitrogen, and usually, sulfur. These macromolecules (proteins) form an intricate meshwork in which cells are embedded to construct tissues. Variations in the relative types of macromolecules and their organization determine the type of extracellular matrix, each adapted to the functional requirements of the tissue. The two main classes of macromolecules that form the extracellular matrix are: glycosaminoglycans, usually linked to proteins (proteoglycans), and fibrous proteins (e.g., COLLAGEN; ELASTIN; FIBRONECTINS; and LAMININ).
An enzyme that, in the presence of ATP and COENZYME A, catalyzes the cleavage of citrate to yield acetyl CoA, oxaloacetate, ADP, and ORTHOPHOSPHATE. This reaction represents an important step in fatty acid biosynthesis. This enzyme was formerly listed as EC 4.1.3.8.
A group of carbon-oxygen lyases. These enzymes catalyze the breakage of a carbon-oxygen bond in polysaccharides leading to an unsaturated product and the elimination of an alcohol. EC 4.2.2.
Oligosaccharides containing two monosaccharide units linked by a glycosidic bond.
An enzyme that, in the course of purine ribonucleotide biosynthesis, catalyzes the conversion of 5'-phosphoribosyl-4-(N-succinocarboxamide)-5-aminoimidazole to 5'-phosphoribosyl-4-carboxamide-5-aminoimidazole and the conversion of adenylosuccinic acid to AMP. EC 4.3.2.2.
A natural high-viscosity mucopolysaccharide with alternating beta (1-3) glucuronide and beta (1-4) glucosaminidic bonds. It is found in the UMBILICAL CORD, in VITREOUS BODY and in SYNOVIAL FLUID. A high urinary level is found in PROGERIA.
Enzymes that catalyze the cleavage of a carbon-carbon bond of a 3-hydroxy acid. (Dorland, 28th ed) EC 4.1.3.
A heteropolysaccharide that is similar in structure to HEPARIN. It accumulates in individuals with MUCOPOLYSACCHARIDOSIS.
A non-vascular form of connective tissue composed of CHONDROCYTES embedded in a matrix that includes CHONDROITIN SULFATE and various types of FIBRILLAR COLLAGEN. There are three major types: HYALINE CARTILAGE; FIBROCARTILAGE; and ELASTIC CARTILAGE.
An enzyme that catalyzes the random hydrolysis of 1,4-linkages between N-acetyl-beta-D-glucosamine and D-glucuronate residues in hyaluronate. (From Enzyme Nomenclature, 1992) There has been use as ANTINEOPLASTIC AGENTS to limit NEOPLASM METASTASIS.
A sulfated mucopolysaccharide initially isolated from bovine cornea. At least two types are known. Type I, found mostly in the cornea, contains D-galactose and D-glucosamine-6-O-sulfate as the repeating unit; type II, found in skeletal tissues, contains D-galactose and D-galactosamine-6-O-sulfate as the repeating unit.
A class of enzymes that catalyze the cleavage of C-C, C-O, and C-N, and other bonds by other means than by hydrolysis or oxidation. (Enzyme Nomenclature, 1992) EC 4.
Enzymes which transfer sulfate groups to various acceptor molecules. They are involved in posttranslational sulfation of proteins and sulfate conjugation of exogenous chemicals and bile acids. EC 2.8.2.
Enzymes that catalyze a reverse aldol condensation. A molecule containing a hydroxyl group and a carbonyl group is cleaved at a C-C bond to produce two smaller molecules (ALDEHYDES or KETONES). EC 4.1.2.
Acids derived from monosaccharides by the oxidation of the terminal (-CH2OH) group farthest removed from the carbonyl group to a (-COOH) group. (From Stedmans, 26th ed)
HYALURONAN-containing proteoglycans found in the EXTRACELLULAR MATRIX of a variety of tissues and organs. Several versican isoforms exist due to multiple ALTERNATIVE SPLICING of the versican MESSENGER RNA.
Large HYALURONAN-containing proteoglycans found in articular cartilage (CARTILAGE, ARTICULAR). They form into aggregates that provide tissues with the capacity to resist high compressive and tensile forces.

Repopulation of different layers of host human Bruch's membrane by retinal pigment epithelial cell grafts. (1/194)

PURPOSE: To determine the morphology of human retinal pigment epithelium (RPE) after reattachment to different ultrastructural layers of human Bruch's membrane (BM). METHODS: Bruch's membrane explants were prepared from eyes of 23 human donors (age range, 11-89 years). The basal lamina of the RPE, inner collagenous layer, and elastin layer were removed sequentially by mechanical and enzymatic techniques. First-passage cells of human RPE (15,000 cells/6 mm explant) from three donors (ages, 52, 64, and 80 years) were plated onto different layers of human BM, and the explants were examined by scanning and transmission electron microscopy up to 21 days later. RESULTS: RPE flattened and extended footplates 6 hours after plating onto basal lamina. Cells remained round 6 and 24 hours after plating onto the inner collagenous, elastin, or outer collagenous layer. The RPE cells became confluent 14 days after plating onto basal lamina but did not become confluent up to 21 days after plating onto the inner collagenous or elastin layer. Sparse round cells were observed 21 days after plating onto deeper layers, suggesting extensive loss of RPE. CONCLUSIONS: The morphology and subsequent behavior of the RPE reattached to BM depends on the anatomic layer of BM available for cell reattachment. The results suggest that the ability of transplanted RPE to repopulate BM in age-related macular degeneration and other disorders may depend on the layer of BM available to serve as a substrate for cell reattachment.  (+info)

Glycosaminoglycans differentially bind HARP and modulate its biological activity. (2/194)

Heparin affin regulatory peptide (HARP) is a polypeptide belonging to a family of heparin binding growth/differentiation factors. The high affinity of HARP for heparin suggests that this secreted polypeptide should also bind to heparan sulfate proteoglycans derived from cell surface and extracellular matrix defined as extracellular compartments. Using Western blot analysis, we detected HARP bound to heparan sulfate proteoglycans in the extracellular compartments of MDA-MB 231 and MC 3T3-E1 as well as NIH3T3 cells overexpressing HARP protein. Heparitinase treatment of BEL cells inhibited HARP-induced cell proliferation, and the biological activity of HARP in this system was restored by the addition of heparin. We report that heparan sulfate, dermatan sulfate, and to a lesser extent, chondroitin sulfate A, displaced HARP bound to the extracellular compartment. Binding analyses with a biosensor showed that HARP bound heparin with fast association and dissociation kinetics (kass = 1.6 x 10(6) M-1 s-1; kdiss = 0.02 s-1), yielding a Kd value of 13 nM; the interaction between HARP and dermatan sulfate was characterized by slower association kinetics (kass = 0.68 x 10(6) M-1 s-1) and a lower affinity (Kd = 51 nM). Exogenous heparin, heparan sulfate, and dermatan sulfate potentiated the growth-stimulatory activity of HARP, suggesting that corresponding proteoglycans could be involved in the regulation of the mitogenic activity of HARP.  (+info)

Sulfation of chondroitin sulfate in human articular cartilage. The effect of age, topographical position, and zone of cartilage on tissue composition. (3/194)

The chondroitin ABC lyase digestion products of normal human femoral condyle articular cartilage and of purified aggrecan were analyzed for their mono- and nonsulfated disaccharide composition. Changes in the total tissue chemistry were most pronounced during the period from birth to 20 years of age, when the -[GlcAbeta,3GalNAc6]- disaccharide content increased from approximately 50% to 85% of the total disaccharide content and there was a concomitant decrease in the content of the 4-sulfated disaccharide. In general, the disaccharide content of the deeper layers of immature cartilage were richer in the 4-sulfated residue than the upper regions of the tissue. As the tissue aged and decreased in thickness, the disaccharide composition became more evenly 6-sulfated. The newly synthesized chondroitin sulfate chains had a similar composition to the endogenous chains and also underwent the same age and zonal changes. The monoclonal antisera 3B3(+) and 2B6(+) were used to immunolocalize the unsaturated 6- and 4-sulfated residues generated at the reducing termini of the chondroitin sulfate chains by digestion with chondroitin ABC lyase, and these analyses indicated that the sulfation pattern at this position did not necessarily reflect the internal disaccharide composition of the chains. In summary, the sulfation pattern of chondroitin sulfate disaccharides from human normal articular cartilage varies with the age of the specimen, the position (topography) on the joint surface, and the zone of cartilage analyzed. Furthermore, these changes in composition are a consequence of both extracellular, post-translational processing of the core protein of aggrecan and changes in the sulfotransferase activity of the chondrocyte.  (+info)

Molecular polymorphism of the syndecans. Identification of a hypo-glycanated murine syndecan-1 splice variant. (4/194)

We have identified a cDNA that encodes a variant form of murine syndecan-1. The variant cDNA lacks the sequence corresponding to the first 132 nucleotides of the third exon of the syndecan-1 gene. The corresponding message is rare. The alternative splice respects the reading frame and deletes 44 amino acids from the protein, joining the S45GS47GT sequence to a variant immediate downstream context. This sequence context initiates with alanine instead of glycine as residue 50, reducing the number of SGXG sequence motifs in the protein from two to one. Expression of this variant syndecan-1 in Madin-Darby canine kidney or MOLT-4 cells yielded a recombinant proteoglycan with a reduced number and clustering of the heparan sulfate chains. Both the conversions of Ala50 and of Lys53 into glycine enhanced the heparan sulfate substitution of the variant protein. These findings support the concept that serine-glycine dipeptide signals for glycosaminoglycan/heparan sulfate synthesis depend on sequence context (Zhang, L., David, G., and Esko, J. D. (1995) J. Biol. Chem. 270, 27127-27135) and imply that alternative splicing mechanisms may in part control the molecular polymorphism of syndecan-1 and, therefore, the efficiency and versatility of this protein in its co-receptor functions.  (+info)

Quantitative alterations of hyaluronan and dermatan sulfate in the hairless mouse dorsal skin exposed to chronic UV irradiation. (5/194)

The quantitative alterations of hyaluronan and dermatan sulfate in the upper dermis (fibrous tissue) and the lower dermis (adipose tissue) of the hairless mouse skin chronically exposed to the UV irradiation as solar-simulating irradiation (lambda(max) 352 nm, UV distribution: 300-310 nm, 0.9%; 310-320 nm, 2.0%; 320-420 nm, 97.1%) were evaluated. Hyaluronan and dermatan sulfate contents in each part of dermis were determined as follows: skin sections on a glass slide prepared by histological technique were processed into the upper dermis and the lower dermis with a small surgical knife, and treated with chondroitinase ABC and ACII in the presence of bacterial collagenase. The resulting unsaturated disaccharides were determined by HPLC method. By applying this method to the UV-irradiated hairless mouse skin, it was found that the chronic UV irradiation increased dermatan sulfate in the upper dermis, whereas an increase of hyaluronan content was not statistically significant. In the lower dermis, on the contrary, both hyaluronan and dermatan sulfate contents remarkably increased as compared with the control mice. Furthermore, the histological study showed the accumulation of the collagen fibers in the lower dermis of the UV-irradiated hairless mouse skin following the disappearance of adipocytes. These findings indicate that the increases of glycosaminoglycan contents in the UV-irradiated skin are related to the accumulation of the extracellular matrix components in the lower dermis.  (+info)

Molecular characterization of a novel basement membrane-associated proteoglycan, leprecan. (6/194)

A monoclonal antibody was used in early studies to identify a novel chondroitin sulfate proteoglycan, secreted by L-2 cells, the core protein of which was approximately 100 kDa. To characterize this proteoglycan core protein at the molecular level, an L-2 cell cDNA library was probed by expression screening and solution hybridization. Northern blot analysis assigned transcript size to approximately 3.1 kilobases and, after contig assembly, the coding region of the mRNA corresponded to 2.18 kilobases. Immunoassays were performed to confirm the identity of this sequence, using a polyclonal antibody raised against an expressed fusion protein encoded by sequence representing the carboxyl half of the molecule. The antibody recognized the core protein in Western blots after prior digestion of the intact proteoglycan with chondroitinase ABC. Immunostaining tissue sections with the same antibody localized the proteoglycan to basement membranes, and expression of the entire sequence in Chinese hamster ovary K-1 cells showed that the protein encoded by the sequence secreted as a chondroitin sulfate proteoglycan. The core protein not only has motifs permitting glycosylation as a proteoglycan, but also possesses the endoplasmic reticulum retrieval signal, KDEL, which suggests that, in addition to its role as a basement membrane component, it may also participate in the secretory pathway of cells.  (+info)

Effects of hyaluronan lyase, hyaluronidase, and chondroitin ABC lyase on mammalian vitreous gel. (7/194)

PURPOSE: To determine the effects of enzymes on mammalian vitreous gel and to thus infer the structural roles of hyaluronan and chondroitin sulfate in the gel. METHODS: The wet weights of bovine vitreous gels were compared before and after incubation with Streptomyces hyaluronan lyase, chondroitin ABC lyase, testicular hyaluronidase, or buffer alone. The extent of hyaluronan depolymerization was determined by chromatography and that of chondroitin sulfate depolymerization by western blot analysis. RESULTS: After digestion with Streptomyces hyaluronan lyase (30 U/gel), the gel wet weight was the same as that of controls (incubated with buffer alone) despite 94% of the hyaluronan having been depolymerized; when digested with 100 U/gel, the gel wet weight decreased (to 57% of original wet weight versus 86% for controls, P = < 0.001) and hyaluronan was completely depolymerized. Chondroitin ABC lyase digestion (0.2 U/gel) resulted in a slight reduction in gel wet weight (90% versus 96%, P = < 0.001) and depolymerization of 88% of the hyaluronan; the presence of fully digested chondroitin sulfate chains was established. Digestions with 100 and 500 U/gel of testicular hyaluronidase resulted in a decrease (P = < 0.001, both cases) in gel wet weight (53% versus 82%, 100 U/gel; 57%, versus 86%, 500 U/gel) with 75% and 97% hyaluronan depolymerization, respectively. CONCLUSIONS: Depolymerization of all vitreous hyaluronan and of chondroitin sulfate resulted in gel wet weight reduction but not gel destruction. Digestion with 30 U/gel of Streptomyces hyaluronan lyase revealed a small pool (6%) of relatively enzyme-resistant hyaluronan that specifically contributed toward maintaining gel wet weight.  (+info)

Identification of a nervous tissue-specific chondroitin sulfate proteoglycan, neurocan, in developing rat retina. (8/194)

PURPOSE: To identify the expression of neurocan, a nervous tissue-specific chondroitin sulfate proteoglycan, in retina and to elucidate its changes during development. METHODS: Expressional changes of neurocan mRNAs in developing rat retinas were investigated by a semiquantitative reverse transcription-polymerase chain reaction (RT-PCR). The localization and characterization of neurocan core proteins were also investigated with the use of Western blot analysis and immunohistochemistry. RESULTS: Gene expression of neurocan was identified in retinas by RT-PCR. Semiquantitative analysis using Southern blot analysis revealed that mRNA expression for neurocan increased at increasing postnatal stages and that it reached its peak around postnatal day 7 (P7). Immunohistochemical studies demonstrated that in differentiating rat retinal (neuroblast) cells weak neurocan immunoreactivities were observed throughout the retina on embryonal days 14 (E14) and E16. During the early postnatal period, the immunoreactivities became most conspicuous in the inner and outer plexiform layers on P7 through P14. In adult retinas, only faint immunostaining was detected. Immunoblot analysis showed two positive bands of 220- and 150-kDa core glycoproteins after treatment with chondroitinase ABC. Further immunoblot analysis revealed that the expression of these two immunolabeled variants was regulated differently during retinal development. CONCLUSIONS: The temporal and spatial regulation of expression of neurocan and its proteolytic variant during retinal development suggest that it may play a role in differentiation and neural network formation.  (+info)

... (EC 4.2.2.20 EC 4.2.2.21, chondroitinase, chondroitin ABC eliminase, chondroitinase ABC) is an enzyme ... Chondroitin+ABC+lyase at the US National Library of Medicine Medical Subject Headings (MeSH) Portal: Biology (EC 4.2.2, ... with systematic name chondroitin ABC lyase. This enzyme catalyses the following chemical reaction Eliminative degradation of ... chondroitin 6-sulfate and dermatan sulfate. Following a spinal cord injury, this enzyme can be used to erode scar tissue that ...
... may refer to: Chondroitin ABC lyase, an enzyme Chondroitin-sulfate-ABC exolyase, an enzyme ... an enzyme This disambiguation page lists articles associated with the title Chondroitin sulfate ABC lyase. If an internal link ...
... chondroitinase ABC (ambiguous), chondroitin ABC lyase (ambiguous), chondroitin sulfate ABC lyase (ambiguous), ChS ABC lyase ( ... chondroitin sulfate ABC exoeliminase, chondroitin sulfate ABC exolyase, and ChS ABC lyase II. Yamagata T, Saito H, Habuchi O, ... "Two distinct chondroitin sulfate ABC lyases. An endoeliminase yielding tetrasaccharides and an exoeliminase preferentially ... The enzyme chondroitin-sulfate-ABC exolyase (EC 4.2.2.21) catalyzes the following process: Exolytic removal of Δ4-unsaturated ...
... chondroitinase ABC (ambiguous), chondroitin ABC lyase (ambiguous), chondroitin sulfate ABC lyase (ambiguous), ChS ABC lyase ( ... chondroitin sulfate ABC endoeliminase, chondroitin sulfate ABC endolyase, and ChS ABC lyase I. Yamagata T, Saito H, Habuchi O, ... "Two distinct chondroitin sulfate ABC lyases. An endoeliminase yielding tetrasaccharides and an exoeliminase preferentially ... The enzyme chondroitin-sulfate-ABC endolyase (EC 4.2.2.20) catalyzes the following process: Endolytic cleavage of (1→4)-β- ...
... an enzyme Chondroitin ABC lyase, an enzyme This set index page lists enzyme articles associated with the same name. If an ...
... chondroitin ABC lyase) and EC 4.2.2.5 (chondroitin AC lyase) EC 4.2.99.7: Now EC 4.2.3.2, ethanolamine-phosphate phospho-lyase ... chondroitin-sulfate-ABC endolyase and EC 4.2.2.21, chondroitin-sulfate-ABC exolyase EC 4.2.2.5: chondroitin AC lyase EC 4.2.2.6 ... chondroitin B lyase EC 4.2.2.20: chondroitin-sulfate-ABC endolyase EC 4.2.2.21: chondroitin-sulfate-ABC exolyase EC 4.2.2.22: ... pectin lyase EC 4.2.2.11: guluronate-specific alginate lyase EC 4.2.2.12: xanthan lyase EC 4.2.2.13: exo-(1→4)-α-D-glucan lyase ...
... chondroitin lyases MeSH D08.811.520.241.700.350.500.500 - chondroitin abc lyase MeSH D08.811.520.241.700.512 - heparin lyase ... polysaccharide-lyases MeSH D08.811.520.241.700.350 - chondroitinases and chondroitin lyases MeSH D08.811.520.241.700.350.500 - ... tyrosine phenol-lyase MeSH D08.811.520.232.300 - amidine-lyases MeSH D08.811.520.232.300.200 - adenylosuccinate lyase MeSH ... ammonia-lyases MeSH D08.811.520.232.400.200 - aspartate ammonia-lyase MeSH D08.811.520.232.400.350 - ethanolamine ammonia-lyase ...
The lyases have mainly been used in heparin/HS studies. The bacterium produces three lyases, heparinases I (EC 4.2.2.7), II (no ... The most prevalent impurity in heparin is dermatan sulfate (DS), also known as chondroitin sulfate B. The building-block of DS ... Vonfremd, Mike; Ibanga, Imaeyen (2008-07-11). "Officials Investigate Infants' Heparin OD at Texas Hospital". ABC News. Archived ... The lyases cleave heparin/HS by a beta elimination mechanism. This action generates an unsaturated double bond between C4 and ...
... hydroxamate ABC transporter}}, EC 7.2.2.17, ferric enterobactin ABC transporter}}, and EC 7.2.2.18, ferric citrate ABC ... EC 3.1.27.6: Now EC 4.6.1.21, Enterobacter ribonuclease}}, since the primary reaction is that of a lyase EC 3.1.27.7: ... unsaturated chondroitin disaccharide hydrolase EC 3.2.1.181: galactan endo-β-1,3-galactanase EC 3.2.1.182: 4-hydroxy-7-methoxy- ... ABC-type polar-amino-acid transporter EC 3.6.3.22: Now EC 7.4.2.2, ABC-type nonpolar-amino-acid transporter EC 3.6.3.23: Now EC ...
Slides were treated with chondroitin ABC lyase (0.15 U/mL) and blocked with 10% normal goat serum for 1 hour. Expressions of ...
chondroitin ABC lyase. Public MeSH Note. 98; see CHONDROITIN LYASES 1975-97. History Note. 98; use CHONDROITIN LYASES 1975-97. ... Chondroitin Lyases [D08.811.520.241.700.350.500] * Chondroitin ABC Lyase [D08.811.520.241.700.350.500.500] ... Carbon-Oxygen Lyases [D08.811.520.241] * Polysaccharide-Lyases [D08.811.520.241.700] * Chondroitinases and Chondroitin Lyases [ ... Chondroitin ABC Lyase Preferred Term Term UI T058755. Date01/01/1999. LexicalTag NON. ThesaurusID NLM (1998). ...
... in basal cell carcinoma by in situ hybridization using chondroitin ABC lyase.. Tsukifuji R; Sakai Y; Hatamochi A; Shinkai H. ...
Chondroitine ABC lyase Entry term(s):. Chondroitin Sulfate ABC Endolyase. Chondroitin-Sulfate-ABC Endolyase. Chondroitinase ABC ... Chondroitin ABC Lyase - Preferred Concept UI. M0029328. Scope note. An enzyme that catalyzes the eliminative degradation of ... Chondroitin ABC Lyase Entry term(s). Chondroitin Sulfate ABC Endolyase Chondroitin-Sulfate-ABC Endolyase Chondroitinase ABC ... do not confuse with CHONDROITIN LYASES. Allowable Qualifiers:. AD administration & dosage. AE adverse effects. AI antagonists ...
chondroitin ABC lyase. Public MeSH Note. 98; see CHONDROITIN LYASES 1975-97. History Note. 98; use CHONDROITIN LYASES 1975-97. ... Chondroitin Lyases [D08.811.520.241.700.350.500] * Chondroitin ABC Lyase [D08.811.520.241.700.350.500.500] ... Carbon-Oxygen Lyases [D08.811.520.241] * Polysaccharide-Lyases [D08.811.520.241.700] * Chondroitinases and Chondroitin Lyases [ ... Chondroitin ABC Lyase Preferred Term Term UI T058755. Date01/01/1999. LexicalTag NON. ThesaurusID NLM (1998). ...
Chondroitin ABC Lyase. 1. + 195. Camptothecin. 1. + 196. Dendrimers. 1. + We do not evaluate or guarantee the accuracy of any ...
Chondroitin ABC Lyase 29% * Inhibitory Postsynaptic Potentials 24% 1 Scopus citations * Prenatal development of neonatal ...
HH-chondroitin ABC lyase represents the first characterized chondroitin lyase from intestinal Firmicutes and offers a viable ... Genome sequence analysis revealed three putative GAG lyases, but only the HH-chondroitin ABC lyase was upregulated in the ... Further characterization of the recombinant HH-chondroitin ABC lyase revealed that it cleaves GAGs predominantly in an exo-mode ... The high specific activity of the characterized chondroitin ABC lyase aids future attempts to develop a commercial ...
Sulfatase N0000005998 Chondroitin N0000168038 Chondroitin ABC Lyase N0000168037 Chondroitin Lyases N0000169197 Chondroitin ... Sulfate Proteoglycans N0000010542 Chondroitin Sulfates N0000168036 Chondroitinases and Chondroitin Lyases N0000167602 ... as Amide-N-Donor N0000168008 Carbon-Nitrogen Lyases N0000167775 Carbon-Oxygen Ligases N0000008169 Carbon-Oxygen Lyases ... Lyase N0000168230 DNA-Activated Protein Kinase N0000169224 DNA-Binding Proteins N0000180242 DNA-Cytosine Methylases N0000168286 ...
G11.427.792.560.180 Chondroitin ABC Lyase D8.586.520.241.700.350.500.500 D8.811.520.241.700.350.500.500 Chondroitin Lyases ... D8.811.520.241.700.350.500 Chondroitinases and Chondroitin Lyases D8.586.277.352.827.180 D8.811.277.352.827.180 D8.586.520.241. ... D8.811.913.200 Aldehyde-Lyases D8.586.520.224.62 D8.811.520.224.62 Aldose-Ketose Isomerases D8.586.399.475.200 D8.811.399.475. ... G9.188.229.552 Lyases D8.586.520 D8.811.520 Lymecycline D4.615.638.638.900.450 Lymnaea B1.644.776.645 B1.500.644.776.645 Lymph ...
Chondroitin ABC eliminase Chondroitin ABC lyase,Chondroitin ABC lyase Chondroitin AC Lyase,Chondroitin AC Lyase Chondroitin AC ... Chondroitin ABC,Lyase, Chondroitin ABC Lyase, Chondroitin AC,Lyase, Chondroitin AC Lyase, Chondroitin B,Lyase, Chondroitin B ... cathepsin B chondroitin ABC lyase,chondroitin ABC lyase chondroitin AC lyase,chondroitin AC lyase chondroitin sulfate, ... Chondroitin AC eliminase Chondroitin AC lyase,Chondroitin AC lyase Chondroitin B Lyase,Chondroitin B Lyase Chondroitin ...
Chondroitin Chondroitin ABC Lyase Chondroitin Lyases Chondroitin Sulfate Proteoglycans Chondroitin Sulfates Chondroitinases and ... Carbon-Nitrogen Lyases Carbon-Oxygen Ligases Carbon-Oxygen Lyases Carbon-Sulfur Ligases Carbon-Sulfur Lyases Carbonated ... Chondroitin Lyases Chondroitinsulfatases Chondroma Chondromalacia Patellae Chondromatosis Chondromatosis, Synovial ... Lyase DNA-Activated Protein Kinase DNA-Binding Proteins DNA-Cytosine Methylases DNA-Directed DNA Polymerase DNA-Directed RNA ...
Chondroitin ABC eliminase Chondroitin ABC lyase,Chondroitin ABC lyase Chondroitin AC Lyase,Chondroitin AC Lyase Chondroitin AC ... Chondroitin ABC,Lyase, Chondroitin ABC Lyase, Chondroitin AC,Lyase, Chondroitin AC Lyase, Chondroitin B,Lyase, Chondroitin B ... cathepsin B chondroitin ABC lyase,chondroitin ABC lyase chondroitin AC lyase,chondroitin AC lyase chondroitin sulfate, ... Chondroitin AC eliminase Chondroitin AC lyase,Chondroitin AC lyase Chondroitin B Lyase,Chondroitin B Lyase Chondroitin ...
... a real-world experience Chondroitin 6-sulphate is required for neuroplasticity and memory in ageing Dynamic loading of human ... sphingosine phosphate lyase 1) modulates neuronal autophagy via phosphatidylethanolamine production Dynamically and ... pancreatic islets and prevents β cell death via ATG16L1 interaction and autophagy regulation Conformational dynamics of the ABC ... solution under subnormothermic conditions Subnanometre-resolution electron cryomicroscopy structure of a heterodimeric ABC ...
Chondroitin ABC Lyase / genetics* Actions. * Search in PubMed * Search in MeSH * Add to Search ... ABC is a bacterial enzyme that cleaves chondroitin sulfate disaccharide chains from CSPGs in the tumor ECM. Wild-type Chase ABC ... Humanized chondroitinase ABC sensitizes glioblastoma cells to temozolomide Alena Cristina Jaime-Ramirez 1 , Nina Dmitrieva 1 , ... Humanized chondroitinase ABC sensitizes glioblastoma cells to temozolomide Alena Cristina Jaime-Ramirez et al. J Gene Med. 2017 ...
... in basal cell carcinoma by in situ hybridization using chondroitin ABC lyase.. Tsukifuji R; Sakai Y; Hatamochi A; Shinkai H. ...
Chondroitin ABC lyase (substance). Code System Preferred Concept Name. Chondroitin ABC lyase (substance). ... Enzyme (substance) {90668006 , SNOMED-CT } Substance with lyase mechanism of action (substance) {21533003 , SNOMED-CT } ... Chondroitin ABC lyase Current Synonym true false 40852019 Chondroitin ABC eliminase Current Synonym true false ...
Chondroitine ABC lyase Entry term(s):. Chondroitin Sulfate ABC Endolyase. Chondroitin-Sulfate-ABC Endolyase. Chondroitinase ABC ... Chondroitin ABC Lyase - Preferred Concept UI. M0029328. Scope note. An enzyme that catalyzes the eliminative degradation of ... Chondroitin ABC Lyase Entry term(s). Chondroitin Sulfate ABC Endolyase Chondroitin-Sulfate-ABC Endolyase Chondroitinase ABC ... do not confuse with CHONDROITIN LYASES. Allowable Qualifiers:. AD administration & dosage. AE adverse effects. AI antagonists ...
In this work, a chondroitin sulfate lyase ABC (Chon-ABC) was successfully cloned, expressed, and characterized. The Km and Vmax ... A Highly Active Chondroitin Sulfate Lyase ABC for Enzymatic Depolymerization of Chondroitin Sulfate. ... Chondroitin AC lyase can hydrolyze chondroitin sulfate A (CS-A), chondroitin sulfate C (CS-C), and hyaluronic acid (HA), making ... Chondroitin AC lyase can efficiently hydrolyze chondroitin sulfate (CS) to low molecule weight chondroitin sulfate, which has ...
... abu gnat2 ad7 abt gnat1 abs ad5 abr ad3 abp ad2 abo ad1 abn anagrapha abl abiotrophy abi excoriation abh abg abf abe abd abc ... isda iscu scopolia isct nonselective iscs iscr glycosylase isca barusiban panniformis indinavir isbt indralin anaerobes lyase ... acetamidomethyl polycyclic gste1 cilostazol grating cd85j inoviridae sigmoidorectal optional tipping hyperoxaluria chondroitin ... antiplatelet glomuvenous hsv2 hsv1 campinasensis cyclohexa phycocyanobilin sylvarum mmh2o bitucarpin gemistocyte hst7 lyases ...
  • 17. Chondroitin ABC lyase digestion of an ascidian dermatan sulfate. (nih.gov)
  • In this study, we developed an on-line reverse-phase high-performance liquid chromatography-electrospray ionization-mass spectrometry (RP-HPLC-ESI-MS) separation and structural characterization of hyaluronan (HA)/chondroitin sulfate (CS)/dermatan sulfate (DS) disaccharides released by enzymatic treatment and derivatized with 2-aminoacridone (AMAC), providing a high-resolution system also applicable by using a further fluorimetric detector (Fp) before ESI-MS spectral acquisition. (unboundmedicine.com)
  • As an important glycosaminoglycan hydrolase, chondroitin lyases can hydrolyze chondroitin sulfate (CS) and release disaccharides and oligosaccharides. (bvsalud.org)
  • Chondroitin AC lyase can hydrolyze chondroitin sulfate A (CS-A), chondroitin sulfate C (CS-C), and hyaluronic acid (HA), making it an essential biocatalyst for the preparation of low molecular weight chondroitin sulfate, analysis of the structure of the chondroitin sulfate, treatment of spinal cord injury, and purification of heparin. (bvsalud.org)
  • Enzymatic preparation of low-molecular-weight chondroitin sulfate (LMWCS) has received increasing attention. (bvsalud.org)
  • In this work, a chondroitin sulfate lyase ABC (Chon-ABC) was successfully cloned, expressed, and characterized. (bvsalud.org)
  • Chondroitin AC lyase can efficiently hydrolyze chondroitin sulfate (CS) to low molecule weight chondroitin sulfate, which has been widely used in clinical therapy, including anti-tumor, anti-oxidation, hypolipidemic, and anti-inflammatory. (bvsalud.org)
  • The characterization of PxchonAC showed that it has specific activities on chondroitin sulfate A, Chondroitin sulfate C and hyaluronic acid with 428.77, 270.57, and 136.06 U mg-1, respectively. (bvsalud.org)
  • The Km and Vmax of PxchonAC were 0.61 mg mL-1 and 670.18 U mg-1 using chondroitin sulfate A as the substrate. (bvsalud.org)
  • Overall, the Chon-ABC from Bacteroides thetaiotaomicron is competitive in large-scale enzymatic preparation of LMWCS for its high activity, stability, and substrate specificity. (bvsalud.org)